Efficacy and safety of short course adjuvant trastuzumab combination chemotherapy in breast cancer.

The Indian Council of Medical Research population-based cancer registry of New Delhi shows the incidence to be 29.3/100,000 of the population in 1994–1995.[ 8 ] Moreover, the Indian Cancer Society's Maharashtra population-based registry shows it to be 26.8 per 100,000 of the population in 2001.[ 4 ] Both these figures are higher than the <19.5 incidence per 100,000 population showed in Globocan 2002 data.[ 9 , 10 ] In India, the age-adjusted incidence shows an increasing trend of 1.6% from Indian Cancer Society's Mumbai cancer registry (metro region) over a 15 years of period (1996–2010).[ 1 , 4 ] Moreover, the projected increase in India's urban population will be to >550 million by 2030.

also in 63,971 other papers